Foley Hoag Represents Ovia Health in Sale to Labcorp

August 12, 2021

Foley Hoag LLP represented Ovuline, Inc. (d/b/a Ovia Health), a digital health company focused on maternity and family benefits for employers and health plans, in its sale to Labcorp (NYSE: LH), a leading global life sciences company. The transaction will extend Labcorp’s position as a go-to source for women’s health insights, open new avenues for personalized care experiences and foster better dialogue between health care providers and their patients.

Ovia Health is a leading digital health platform for women and families. The company’s mobile apps for fertility, pregnancy, and parenting empower people to take control of their healthcare and start families with confidence.

Foley Hoag attorneys Alex Aber, Zohar Nevo, Patricia Pérez Elias, Earl Mellott, Chris Natkanski, Ellie Kang and Chasse Osborn represented Ovia Health in the transaction. 

About Foley Hoag LLP

Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.